Margaritis Avgeris

32PUBLICATIONS
55CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsHaematological tumoursCancer geneticsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 09, 2025
Loss of METTL3 m6A methyltransferase results in short-term progression and poor treatment outcome of bladder cancer patients.

Katerina-Marina Pilala, Stella Koroneou, Maria-Alexandra Papadimitriou

|Sep 01, 2025
NEAT1 lncRNA overexpression results in short-term progression and poor treatment outcome in childhood B-ALL.

Marieta Xagorari, Antonios Marmarinos, Dimitrios Doganis

|Mar 26, 2025
Lifestyle and Biochemical Parameters That May Hamper Immune Responses in Pediatric Patients After Immunization with the BNT162b2 mRNA COVID-19 Vaccine.

Anthie Damianaki, Antonios Marmarinos, Margaritis Avgeris

|Apr 05, 2024
MIR145 Core Promoter Methylation in Pretreatment Cell-Free DNA: A Liquid Biopsy Tool for Muscle-Invasive Bladder Cancer Treatment Outcome.

Katerina-Marina Pilala, Georgios Kotronopoulos, Panagiotis Levis

|Feb 28, 2024
Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRFHisGTG results in patients' poor treatment outcome.

Konstantinos Soureas, Maria-Alexandra Papadimitriou, Panagiotis Malandrakis

Pageof 6